These mouse models of NPM1-mutated AML have certainly been important for demonstrating that the NPM1 mutation alone, though inducing deregulated cell growth, displayed a low leukemogenic activity in vivo, but can lead to leukemia progression after long latency and acquisition of collaborating mutations [106]. Here, NPM1 is linked to leukemia.